» Articles » PMID: 3877182

Corticotropin-releasing Factor-like Immunoreactivity in Senile Dementia of the Alzheimer Type. Reduced Cortical and Striatal Concentrations

Overview
Journal JAMA
Specialty General Medicine
Date 1985 Dec 6
PMID 3877182
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The concentration of corticotropin-releasing factor-like immunoreactivity (CRF-LI) in the human central nervous system was measured by radioimmunoassay in postmortem tissue of control patients and in those with histologically confirmed senile dementia of the Alzheimer type (SDAT). In the controls, CRF-LI was found in high concentrations in the hypothalamus and frontal cortex (Brodmann's area 10), in moderate concentrations in amygdala, substantia innominata, temporal and parietal cortex (Brodmann's areas 38 and 7), and the caudate nucleus, and in low concentrations in posterior hippocampus and nucleus accumbens. A marked reduction in the concentration of CRF-LI was observed in the frontal and temporal cortex (approximately 50%) as well as in the caudate nucleus (approximately 70%) in the SDAT group. The present findings suggest that neurons containing corticotropin-releasing factor are pathologically altered in SDAT, in addition to the previously described cholinergic and somatostatinergic neuronal degeneration.

Citing Articles

Dissecting the shared genetic architecture between Alzheimer's disease and frailty: a cross-trait meta-analyses of genome-wide association studies.

Enduru N, Fernandes B, Zhao Z Front Genet. 2024; 15():1376050.

PMID: 38706793 PMC: 11069310. DOI: 10.3389/fgene.2024.1376050.


Discovering new peripheral plasma biomarkers to identify cognitive decline in type 2 diabetes.

Yu H, Gao Y, He T, Li M, Zhang Y, Zheng J Front Cell Dev Biol. 2022; 10:818141.

PMID: 36506101 PMC: 9729784. DOI: 10.3389/fcell.2022.818141.


Corticotropin releasing factor-binding protein (CRF-BP) as a potential new therapeutic target in Alzheimer's disease and stress disorders.

Vandael D, Gounko N Transl Psychiatry. 2019; 9(1):272.

PMID: 31641098 PMC: 6805916. DOI: 10.1038/s41398-019-0581-8.


Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology.

Ishii M, Iadecola C Cell Metab. 2015; 22(5):761-76.

PMID: 26365177 PMC: 4654127. DOI: 10.1016/j.cmet.2015.08.016.


An anxiolytic role for CRF receptor type 1 in the globus pallidus.

Sztainberg Y, Kuperman Y, Justice N, Chen A J Neurosci. 2011; 31(48):17416-24.

PMID: 22131403 PMC: 6623832. DOI: 10.1523/JNEUROSCI.3087-11.2011.